Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Schedule Study”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01938846
What this trial is testing

BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors

Who this might be right for
Neoplasms
Boehringer Ingelheim 90
Large-scale testing (Phase 3)Study completedNCT00169455
What this trial is testing

Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants

Who this might be right for
Rotavirus Gastroenteritis
GlaxoSmithKline 450
Early research (Phase 1)Study completedNCT00850616
What this trial is testing

Three-Dose Regimen of MRKAd5+6 Trigene (V526) in Healthy Adults (V526-001)(COMPLETED)

Who this might be right for
HIVHIV Infections
Merck Sharp & Dohme LLC 147
Large-scale testing (Phase 3)Study completedNCT02670538
What this trial is testing

Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder

Who this might be right for
Bipolar DisorderDepression
Forest Laboratories 493
Early research (Phase 1)Study completedNCT00003755
What this trial is testing

Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid Tumor

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT01152385
What this trial is testing

Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus Patients

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 224
Large-scale testing (Phase 3)Study completedNCT00335452
What this trial is testing

Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS

Who this might be right for
Acute Coronary DiseaseAngina Unstable
Sanofi 25,086
Post-approval studies (Phase 4)WithdrawnNCT02918708
What this trial is testing

Assessment of Novel Pneumococcal Conjugate Vaccination Scheduled in UK Infants

Who this might be right for
VaccinationImmunization
Public Health England
Large-scale testing (Phase 3)Study completedNCT00656188
What this trial is testing

Placebo-controlled Study Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction

Who this might be right for
Erectile Dysfunction
Bayer 463
Early research (Phase 1)Study completedNCT00011479
What this trial is testing

Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT00384228
What this trial is testing

A Phase l/ll Study of AMN107 in Adult Patients With Glivec-intolerant CML or Relapsed-refractory Ph+ALL

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)Study completedNCT00062751
What this trial is testing

Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms

Who this might be right for
Breast Neoplasms
Wyeth is now a wholly owned subsidiary of Pfizer 108
Testing effectiveness (Phase 2)Study completedNCT02316106
What this trial is testing

Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 123
Large-scale testing (Phase 3)Study completedNCT00141258
What this trial is testing

Pregabalin Epilepsy Add-On Trial

Who this might be right for
Partial Seizures
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 178
Early research (Phase 1)Study completedNCT03987685
What this trial is testing

Evaluate Oral Topotecan With HM30181A Monotherapy in Patients With Advanced Malignancies

Who this might be right for
Solid Tumor
Athenex, Inc. 10
Early research (Phase 1)Active Not RecruitingNCT06320535
What this trial is testing

Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™

Who this might be right for
Malaria,Falciparum
University of Oxford 36
Early research (Phase 1)Study completedNCT00014248
What this trial is testing

Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors

Who this might be right for
CachexiaUnspecified Adult Solid Tumor, Protocol Specific
Dartmouth-Hitchcock Medical Center
Testing effectiveness (Phase 2)Study completedNCT00526045
What this trial is testing

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

Who this might be right for
Breast CancerHematologic Neoplasms
Novartis Pharmaceuticals 117
Large-scale testing (Phase 3)Study completedNCT01381575
What this trial is testing

Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,447
Testing effectiveness (Phase 2)Ended earlyNCT03866187
What this trial is testing

Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection

Who this might be right for
Hepatitis B, Chronic
GlaxoSmithKline 236
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation